Loading…
Based on limited metadata, this FDA Warning Letter was issued to Genetech, Inc. on November 29, 2018, regarding biologics manufacturing or operations. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined, though FDA Warning Letters typically address compliance issues related to manufacturing practices, quality control, labeling, or regulatory submissions. The letter was issued under FDA's biologics regulatory authority, which oversees products including vaccines, blood products, and therapeutic proteins. Additional details would require review of the complete correspondence.